Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
  • Page of 1
Richardson NJ, Shepherd R, Elliman NA. Current attitudes and future influences on meat consumption in the U.K. Appetite. 1993 Aug;21(1):41-51. doi: 10.1006/appe.1993.1035. PubMed PMID: 8239634.
Richardson NJ, Booth DA. Multiple physical patterns in judgements of the creamy texture of milks and creams. Acta Psychol (Amst). 1993 Oct;84(1):93-101. doi: 10.1016/0001-6918(93)90075-3. PubMed PMID: 8237459.
Richardson NJ, Macfie HJ, Shepherd R. Consumer attitudes to meat eating. Meat Sci. 1994;36(1-2):57-65. doi: 10.1016/0309-1740(94)90033-7. PubMed PMID: 22061452.
Richardson NJ. UK consumer perceptions of meat. Proc Nutr Soc. 1994 Jul;53(2):281-7. doi: 10.1079/pns19940033. Review. PubMed PMID: 7972142.
Rogers PJ, Richardson NJ, Dernoncourt C. Caffeine use: is there a net benefit for mood and psychomotor performance?. Neuropsychobiology. 1995;31(4):195-9. doi: 10.1159/000119192. Review. PubMed PMID: 7659200.
Rogers PJ, Richardson NJ, Elliman NA. Overnight caffeine abstinence and negative reinforcement of preference for caffeine-containing drinks. Psychopharmacology (Berl). 1995 Aug;120(4):457-62. doi: 10.1007/BF02245818. PubMed PMID: 8539327.
Richardson NJ, Rogers PJ, Elliman NA, O'Dell RJ. Mood and performance effects of caffeine in relation to acute and chronic caffeine deprivation. Pharmacol Biochem Behav. 1995 Oct;52(2):313-20. doi: 10.1016/0091-3057(95)00029-v. PubMed PMID: 8577796.
Richardson NJ, Rogers PJ, Elliman NA. Conditioned flavour preferences reinforced by caffeine consumed after lunch. Physiol Behav. 1996 Jul;60(1):257-63. doi: 10.1016/0031-9384(95)02203-1. PubMed PMID: 8804673.
Beer BE, Doncel GF, Krebs FC, Shattock RJ, Fletcher PS, Buckheit RW Jr, Watson K, Dezzutti CS, Cummins JE, Bromley E, Richardson-Harman N, Pallansch LA, Lackman-Smith C, Osterling C, Mankowski M, Miller SR, Catalone BJ, Welsh PA, Howett MK, Wigdahl B, Turpin JA, Reichelderfer P. In vitro preclinical testing of nonoxynol-9 as potential anti-human immunodeficiency virus microbicide: a retrospective analysis of results from five laboratories. Antimicrob Agents Chemother. 2006 Feb;50(2):713-23. doi: 10.1128/AAC.50.2.713-723.2006. PubMed PMID: 16436731; PubMed Central PMCID: PMC1366899.
Richardson-Harman NJ, Booth DA. Do you like the sight or the feel of milk in coffee? Ecology and effortful attention in differential acuity and preference for sensed effects of milk substitute in vended coffee. Appetite. 2006 Mar;46(2):130-6. doi: 10.1016/j.appet.2005.11.006. Epub 2006 Jan 27. PubMed PMID: 16443305.
Fichorova RN, Richardson-Harman N, Alfano M, Belec L, Carbonneil C, Chen S, Cosentino L, Curtis K, Dezzutti CS, Donoval B, Doncel GF, Donaghay M, Grivel JC, Guzman E, Hayes M, Herold B, Hillier S, Lackman-Smith C, Landay A, Margolis L, Mayer KH, Pasicznyk JM, Pallansch-Cokonis M, Poli G, Reichelderfer P, Roberts P, Rodriguez I, Saidi H, Sassi RR, Shattock R, Cummins JE Jr. Biological and technical variables affecting immunoassay recovery of cytokines from human serum and simulated vaginal fluid: a multicenter study. Anal Chem. 2008 Jun 15;80(12):4741-51. doi: 10.1021/ac702628q. Epub 2008 May 17. PubMed PMID: 18484740; PubMed Central PMCID: PMC2646866.
Richardson-Harman N, Lackman-Smith C, Fletcher PS, Anton PA, Bremer JW, Dezzutti CS, Elliott J, Grivel JC, Guenthner P, Gupta P, Jones M, Lurain NS, Margolis LB, Mohan S, Ratner D, Reichelderfer P, Roberts P, Shattock RJ, Cummins JE Jr. Multisite comparison of anti-human immunodeficiency virus microbicide activity in explant assays using a novel endpoint analysis. J Clin Microbiol. 2009 Nov;47(11):3530-9. doi: 10.1128/JCM.00673-09. Epub 2009 Sep 2. PubMed PMID: 19726602; PubMed Central PMCID: PMC2772583.
Lackman-Smith CS, Snyder BA, Marotte KM, Osterling MC, Mankowski MK, Jones M, Nieves-Duran L, Richardson-Harman N, Cummins JE Jr, Sanders-Beer BE. Safety and anti-HIV assessments of natural vaginal cleansing products in an established topical microbicides in vitro testing algorithm. AIDS Res Ther. 2010 Jul 9;7:22. doi: 10.1186/1742-6405-7-22. PubMed PMID: 20618951; PubMed Central PMCID: PMC2913913.
Buchman GW, Cohen ME, Xiao Y, Richardson-Harman N, Silvera P, DeTolla LJ, Davis HL, Eisenberg RJ, Cohen GH, Isaacs SN. A protein-based smallpox vaccine protects non-human primates from a lethal monkeypox virus challenge. Vaccine. 2010 Sep 14;28(40):6627-36. doi: 10.1016/j.vaccine.2010.07.030. Epub 2010 Jul 24. PubMed PMID: 20659519; PubMed Central PMCID: PMC2939220.
Anton PA, Cranston RD, Kashuba A, Hendrix CW, Bumpus NN, Richardson-Harman N, Elliott J, Janocko L, Khanukhova E, Dennis R, Cumberland WG, Ju C, Carballo-Diéguez A, Mauck C, McGowan I. RMP-02/MTN-006: A phase 1 rectal safety, acceptability, pharmacokinetic, and pharmacodynamic study of tenofovir 1% gel compared with oral tenofovir disoproxil fumarate. AIDS Res Hum Retroviruses. 2012 Nov;28(11):1412-21. doi: 10.1089/aid.2012.0262. Epub 2012 Oct 9. PubMed PMID: 22943559; PubMed Central PMCID: PMC3484811.
Richardson-Harman N, Mauck C, McGowan I, Anton P. Dose-response relationship between tissue concentrations of UC781 and explant infectibility with HIV type 1 in the RMP-01 rectal safety study. AIDS Res Hum Retroviruses. 2012 Nov;28(11):1422-33. doi: 10.1089/AID.2012.0073. Epub 2012 Sep 20. PubMed PMID: 22900504; PubMed Central PMCID: PMC3484735.
Dezzutti CS, Uranker K, Bunge KE, Richardson-Harman N, Macio I, Hillier SL. HIV-1 infection of female genital tract tissue for use in prevention studies. J Acquir Immune Defic Syndr. 2013 Aug 15;63(5):548-54. doi: 10.1097/QAI.0b013e318291f331. PubMed PMID: 23514957; PubMed Central PMCID: PMC3760971.
Yang KH, Hendrix C, Bumpus N, Elliott J, Tanner K, Mauck C, Cranston R, McGowan I, Richardson-Harman N, Anton PA, Kashuba AD. A multi-compartment single and multiple dose pharmacokinetic comparison of rectally applied tenofovir 1% gel and oral tenofovir disoproxil fumarate. PLoS One. 2014;9(10):e106196. doi: 10.1371/journal.pone.0106196. eCollection 2014. PubMed PMID: 25350119; PubMed Central PMCID: PMC4211672.
Richardson-Harman N, Hendrix CW, Bumpus NN, Mauck C, Cranston RD, Yang K, Elliott J, Tanner K, McGowan I, Kashuba A, Anton PA. Correlation between compartmental tenofovir concentrations and an ex vivo rectal biopsy model of tissue infectibility in the RMP-02/MTN-006 phase 1 study. PLoS One. 2014;9(10):e111507. doi: 10.1371/journal.pone.0111507. eCollection 2014. PubMed PMID: 25350130; PubMed Central PMCID: PMC4211741.
McGowan I, Janocko L, Burneisen S, Bhat A, Richardson-Harman N. Variability of cytokine gene expression in intestinal tissue and the impact of normalization with the use of reference genes. Cytokine. 2015 Jan;71(1):81-8. doi: 10.1016/j.cyto.2014.08.010. Epub 2014 Sep 29. PubMed PMID: 25265568.
Mcgowan I, Cranston RD, Duffill K, Siegel A, Engstrom JC, Nikiforov A, Jacobson C, Rehman KK, Elliott J, Khanukhova E, Abebe K, Mauck C, Spiegel HM, Dezzutti CS, Rohan LC, Marzinke MA, Hiruy H, Hendrix CW, Richardson-Harman N, Anton PA. A Phase 1 Randomized, Open Label, Rectal Safety, Acceptability, Pharmacokinetic, and Pharmacodynamic Study of Three Formulations of Tenofovir 1% Gel (the CHARM-01 Study). PLoS One. 2015;10(5):e0125363. doi: 10.1371/journal.pone.0125363. eCollection 2015. PubMed PMID: 25942472; PubMed Central PMCID: PMC4420274.
Chen BA, Panther L, Marzinke MA, Hendrix CW, Hoesley CJ, van der Straten A, Husnik MJ, Soto-Torres L, Nel A, Johnson S, Richardson-Harman N, Rabe LK, Dezzutti CS. Phase 1 Safety, Pharmacokinetics, and Pharmacodynamics of Dapivirine and Maraviroc Vaginal Rings: A Double-Blind Randomized Trial. J Acquir Immune Defic Syndr. 2015 Nov 1;70(3):242-9. doi: 10.1097/QAI.0000000000000702. PubMed PMID: 26034880; PubMed Central PMCID: PMC4607587.
Bunge KE, Dezzutti CS, Rohan LC, Hendrix CW, Marzinke MA, Richardson-Harman N, Moncla BJ, Devlin B, Meyn LA, Spiegel HM, Hillier SL. A Phase 1 Trial to Assess the Safety, Acceptability, Pharmacokinetics, and Pharmacodynamics of a Novel Dapivirine Vaginal Film. J Acquir Immune Defic Syndr. 2016 Apr 15;71(5):498-505. doi: 10.1097/QAI.0000000000000897. PubMed PMID: 26565716; PubMed Central PMCID: PMC5040830.
Thurman AR, Chandra N, Yousefieh N, Zalenskaya I, Kimble T, Asin S, Rollenhagen C, Anderson SM, Herold B, Mesquita PM, Richardson-Harman N, Cunningham T, Schwartz JL, Doncel GF. Comparison of Follicular and Luteal Phase Mucosal Markers of HIV Susceptibility in Healthy Women. AIDS Res Hum Retroviruses. 2016 Jun;32(6):547-60. doi: 10.1089/AID.2015.0264. Epub 2016 Feb 10. PubMed PMID: 26750085; PubMed Central PMCID: PMC4892231.
Dezzutti CS, Richardson-Harman N, Rohan LC, Marzinke MA, Hoesley CJ, Panther L, Johnson S, Nuttall JP, Nel A, Chen BA. Pharmacodynamic correlations using fresh and cryopreserved tissue following use of vaginal rings containing dapivirine and/or maraviroc in a randomized, placebo controlled trial. Medicine (Baltimore). 2016 Jul;95(28):e4174. doi: 10.1097/MD.0000000000004174. PubMed PMID: 27428211; PubMed Central PMCID: PMC4956805.
McGowan I, Dezzutti CS, Siegel A, Engstrom J, Nikiforov A, Duffill K, Shetler C, Richardson-Harman N, Abebe K, Back D, Else L, Egan D, Khoo S, Egan JE, Stall R, Williams PE, Rehman KK, Adler A, Brand RM, Chen B, Achilles S, Cranston RD. Long-acting rilpivirine as potential pre-exposure prophylaxis for HIV-1 prevention (the MWRI-01 study): an open-label, phase 1, compartmental, pharmacokinetic and pharmacodynamic assessment. Lancet HIV. 2016 Dec;3(12):e569-e578. doi: 10.1016/S2352-3018(16)30113-8. Epub 2016 Sep 16. PubMed PMID: 27658864; NIHMSID:NIHMS997697.
Richardson-Harman N, Parody R, Anton P, McGowan I, Doncel G, Thurman AR, Herrera C, Kordy K, Fox J, Tanner K, Swartz G, Dezzutti CS. Analytical Advances in the Ex Vivo Challenge Efficacy Assay. AIDS Res Hum Retroviruses. 2017 Apr;33(4):395-403. doi: 10.1089/AID.2016.0073. Epub 2016 Dec 16. PubMed PMID: 27841671; PubMed Central PMCID: PMC5372762.
Thurman AR, Yousefieh N, Chandra N, Kimble T, Asin S, Rollenhagen C, Anderson SM, Herold BC, Freiermuth JL, Starkman BS, Mesquita PMM, Richardson-Harman N, Cunningham T, Hillier S, Rabe L, Schwartz JL, Doncel GF. Comparison of Mucosal Markers of Human Immunodeficiency Virus Susceptibility in Healthy Premenopausal Versus Postmenopausal Women. AIDS Res Hum Retroviruses. 2017 Aug;33(8):807-819. doi: 10.1089/AID.2016.0320. Epub 2017 May 16. PubMed PMID: 28398069; PubMed Central PMCID: PMC5564035.
Cranston RD, Regueiro M, Hashash J, Baker JR, Richardson-Harman N, Janocko L, McGowan I. A Pilot Study of the Prevalence of Anal Human Papillomavirus and Dysplasia in a Cohort of Patients With IBD. Dis Colon Rectum. 2017 Dec;60(12):1307-1313. doi: 10.1097/DCR.0000000000000878. PubMed PMID: 29112567.
Bunge KE, Dezzutti CS, Hendrix CW, Marzinke MA, Spiegel HML, Moncla BJ, Schwartz JL, Meyn LA, Richardson-Harman N, Rohan LC, Hillier SL. FAME-04: A Phase 1 trial to assess the safety, acceptability, pharmacokinetics and pharmacodynamics of film and gel formulations of tenofovir. J Int AIDS Soc. 2018 Aug;21(8):e25156. doi: 10.1002/jia2.25156. PubMed PMID: 30101439; PubMed Central PMCID: PMC6088248.
Hoesley CJ, Chen BA, Anderson PL, Dezzutti CS, Strizki J, Sprinkle C, Heard F, Bauermeister J, Hall W, Jacobson C, Berthiaume J, Mayo A, Gundacker H, Richardson-Harman N, Piper J. Phase 1 Safety and Pharmacokinetics Study of MK-2048/Vicriviroc (MK-4176)/MK-2048A Intravaginal Rings. Clin Infect Dis. 2019 Mar 19;68(7):1136-1143. doi: 10.1093/cid/ciy653. PubMed PMID: 30289435; PubMed Central PMCID: PMC6424075.
What would you like to do?
  • Page of 1